Результати пошуку - Baselga, Josè
- Показ 1 - 20 результатів із 202
- На наступну сторінку
-
1
Pharmacology in the Era of Targeted Therapies: The Case of PI3K Inhibitors за авторством Toska, Eneda, Baselga, José
Опубліковано 2016Текст -
2
Targeted therapies for breast cancer за авторством Higgins, Michaela J., Baselga, José
Опубліковано 2011Текст -
3
-
4
-
5
Treatment of HER2-Positive Metastatic Breast Cancer за авторством Swain, Sandra M., Clark, Emma, Baselga, José
Опубліковано 2015Текст -
6
Implementing Genome-Driven Oncology за авторством Hyman, David M., Taylor, Barry S., Baselga, José
Опубліковано 2017Текст -
7
A view on drug resistance in cancer за авторством Vasan, Neil, Baselga, José, Hyman, David M.
Опубліковано 2019Текст -
8
Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silico based mechanism за авторством Fuentes, Gloria, Scaltriti, Maurizio, Baselga, José, Verma, Chandra S
Опубліковано 2011Текст -
9
Advances in the management of HER2-positive early breast cancer за авторством Baselga, José, Coleman, Robert E., Cortés, Javier, Janni, Wolfgang
Опубліковано 2017Текст -
10
-
11
-
12
The Carboxy-terminal Cysteine of the Tetraspanin L6 Antigen Is Required for Its Interaction with SITAC, a Novel PDZ Protein за авторством Borrell-Pagès, Maria, Fernández-Larrea, Juan, Borroto, Aldo, Rojo, Federico, Baselga, José, Arribas, Joaquín
Опубліковано 2000Текст -
13
Proteomic Identification of Desmoglein 2 and Activated Leukocyte Cell Adhesion Molecule as Substrates of ADAM17 and ADAM10 by Difference Gel Electrophoresis за авторством Bech-Serra, Joan J., Santiago-Josefat, Belén, Esselens, Cary, Saftig, Paul, Baselga, José, Arribas, Joaquín, Canals, Francesc
Опубліковано 2006Текст -
14
Biosynthesis of tumorigenic HER2 C-terminal fragments by alternative initiation of translation за авторством Anido, Judit, Scaltriti, Maurizio, Bech Serra, Joan Josep, Josefat, Belén Santiago, Rojo Todo, Federico, Baselga, José, Arribas, Joaquín
Опубліковано 2006Текст -
15
Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance за авторством Wehrenberg-Klee, Eric, Turker, N. Selcan, Heidari, Pedram, Larimer, Benjamin, Juric, Dejan, Baselga, José, Scaltriti, Maurizio, Mahmood, Umar
Опубліковано 2016Текст -
16
Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-cont... за авторством Miles, David, Baselga, José, Amadori, Dino, Sunpaweravong, Patrapim, Semiglazov, Vladimir, Knott, Adam, Clark, Emma, Ross, Graham, Swain, Sandra M.
Опубліковано 2013Текст -
17
Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial за авторством Bonner, James, Giralt, Jordi, Harari, Paul, Spencer, Sharon, Schulten, Jeltje, Hossain, Anwar, Chang, Shao-Chun, Chin, Steve, Baselga, José
Опубліковано 2016Текст -
18
TARGETING THE MUC1-C ONCOPROTEIN DOWNREGULATES HER2 ACTIVATION AND ABROGATES TRASTUZUMAB RESISTANCE IN BREAST CANCER CELLS за авторством Raina, Deepak, Uchida, Yasumitsu, Kharbanda, Akriti, Rajabi, Hasan, Panchamoorthy, Govind, Jin, Caining, Kharbanda, Surender, Scaltriti, Maurizio, Baselga, Jose, Kufe, Donald
Опубліковано 2013Текст -
19
Molecular Features and Survival Outcomes of the Intrinsic Subtypes Within HER2-Positive Breast Cancer за авторством Prat, Aleix, Carey, Lisa A., Adamo, Barbara, Vidal, Maria, Tabernero, Josep, Cortés, Javier, Parker, Joel S., Perou, Charles M., Baselga, José
Опубліковано 2014Текст -
20
An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors за авторством Jonas, Oliver, Landry, Heather M., Fuller, Jason E., Santini, John T., Baselga, Jose, Tepper, Robert I., Cima, Michael J., Langer, Robert
Опубліковано 2015Текст